Parabolic Drugs informs about compliance certificate

30 Oct 2018 Evaluate

Pursuant to Regulation 40 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parabolic Drugs has informed about Compliance Report on Transfer or Transmission or Transposition of Securities of the Company for the Quarter/ Half Year ended on 30th September, 2018.

The above information is a part of company’s filings submitted to BSE. 

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×